This study, called ART-Pro, is looking at new ways to use MRI (magnetic resonance imaging) to find prostate cancer that needs treatment. It's comparing standard MRI (mpMRI) with two newer techniques: biparametric MRI (bpMRI) and Restriction Spectrum Imaging (RSIrs). The goal is to see if these newer methods can help doctors who aren't prostate MRI experts find important cancers as well as experts can, and without needing an IV (intravenous) contrast injection. You might be able to join if you are a man aged 18 or older, have been referred for a prostate MRI because your doctor suspects prostate cancer, and your MRI can follow a specific procedure. The study will measure how many patients are diagnosed with a significant prostate cancer (grade group ≥2) after 6 months. The current recruitment status is unclear.

Study design

This is an observational study planning to enroll 500 participants across 5 centers. It will compare different MRI techniques for detecting prostate cancer.

What's involved

You will have an MRI scan using a specific protocol. Your medical outcomes, like biopsy results or surgery information, will be collected after you join.

Compensation

Not stated in the trial record.

Follow-up

Patients will be followed after initial enrollment to collect medical outcomes, such as biopsy results or surgery pathology, with the primary endpoint measured at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.